| 1 |
33664385 | Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. | 2021 Mar 4 |
1 |
| 2 |
34795594 | Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase. | 2021 |
1 |
| 3 |
30831128 | Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. | 2019 Jul |
6 |
| 4 |
26518357 | The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G. | 2016 May |
9 |
| 5 |
25713534 | Herbal medicines for the treatment of cancer chemotherapy-induced side effects. | 2015 |
1 |
| 6 |
24195516 | Relationship between the expression of CES2, UGT1A1, and GUSB in colorectal cancer tissues and aberrant methylation. | 2014 |
2 |
| 7 |
24439671 | Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells. | 2014 Feb |
1 |
| 8 |
25260839 | Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11. | 2014 Sep |
1 |
| 9 |
23690068 | Molecular insights into microbial β-glucuronidase inhibition to abrogate CPT-11 toxicity. | 2013 Aug |
1 |
| 10 |
22535688 | Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors. | 2012 Aug |
3 |
| 11 |
21350582 | Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β-glucuronidase in tumors. | 2011 Jun |
3 |
| 12 |
19372567 | Local enzymatic hydrolysis of an endogenously generated metabolite can enhance CPT-11 anticancer efficacy. | 2009 Apr |
5 |
| 13 |
18927500 | Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. | 2008 Dec |
1 |
| 14 |
16842384 | The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours. | 2006 Jul |
8 |
| 15 |
12617927 | Cancer chemotherapy: a SN-38 (7-ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug MonoTherapy) strategy. | 2003 Mar 10 |
1 |
| 16 |
14534729 | The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumours. | 2003 Nov-Dec |
7 |
| 17 |
11350876 | Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. | 2001 May |
1 |
| 18 |
10999728 | Factors involved in prolongation of the terminal disposition phase of SN-38: clinical and experimental studies. | 2000 Sep |
1 |
| 19 |
9726089 | Pharmacology of irinotecan. | 1998 Aug |
3 |